Effects of SugarCut® Unripe Guava Fruit Extract on Blood Glucose Regulation

Last updated: April 12, 2024
Sponsor: National Yang Ming University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Diabetes Prevention

Diabetes And Hypertension

Treatment

SugarCut® Unripe Guava Fruit Extract

Placebo group

Clinical Study ID

NCT06330948
NYCU112183AEF
  • Ages 20-60
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

Guava (Psidium guajava) belongs to the Myrtle family. It is a tropical and subtropical fruit native to the Americas. Ripe guava fruit is sweet and delicious. It is rich in vitamins A, C and trace elements such as phosphorus, calcium and magnesium. In traditional medicine, guava fruit can be eaten raw, and the roots can treat stomach problems, abdominal pain, dysentery, and diabetes; the leaves can treat diabetes, abdominal pain, rheumatism, antipyretic, stomachache, anthelmintic, cholera, vomiting, diarrhea, enteritis and other symptoms. Guava leaf extract contains polyphenols. Studies have shown that guava leaf has antioxidant, blood sugar regulating and anti-cancer effects. Not only guava leaves, research has found that guava fruits are rich in vitamins, fiber and antioxidants, which have anti-inflammatory and anti-cancer effects. Preliminary research has found that the extract of red guava young fruit has more active ingredients - saponins and total polyphenol content, and its antioxidant capacity is also higher than that of mature guava. In vitro studies have found that guava fruit extract can increase the expression of GLUT4 gene and promote the entry of blood sugar into cells. At the same time, guava fruit extract can inhibit the formation of final glycated proteins (AGEs). The purpose of this study is to explore the effect of guava fruit extract on blood sugar regulation in humans and to evaluate its potential to be developed as a blood sugar regulation supplement.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Adults aged 20-60.
  2. Fasting blood glucose level is between 100 ~ 126 mg/dL.

Exclusion

Exclusion Criteria:

  1. Patients with renal insufficiency and kidney dialysis.
  2. Cancer patients.
  3. Those taking blood sugar regulation-related drugs.
  4. Have a history of guava allergy
  5. People suffering from mental illness
  6. Pregnant and breastfeeding women
  7. Long-term use of blood sugar regulating supplements

Study Design

Total Participants: 60
Treatment Group(s): 2
Primary Treatment: SugarCut® Unripe Guava Fruit Extract
Phase:
Study Start date:
April 01, 2024
Estimated Completion Date:
January 31, 2025

Study Description

This trial adopted a double-blind placebo-controlled parallel testing design. Subjects will be randomly assigned to the placebo group and the SugarCut® Guava Extract group, with 30 people in each group. Before the trial (week 0), subjects are required to undergo fasting blood collection and height, weight, and blood pressure examinations. Afterwards, the test samples were given to the subjects for 8 consecutive weeks, and they were reviewed for evaluation at the 4th and 8th weeks, and fasting blood collection and height, weight, and blood pressure examinations were performed.

Connect with a study center

  • National Yang Ming Chiao Tung University

    Taipei, Beitou Dist. 112
    Taiwan

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.